BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Deng GM, Song HB, Du ZZ, Xue YW, Song HJ, Li YZ. Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor. World J Gastroenterol 2024; 30(8): 863-880 [PMID: PMC10950641 DOI: 10.3748/wjg.v30.i8.863]
URL: https://www.wjgnet.com/1007-9327/full/v30/i8/863.htm
Number Citing Articles
1
Vasile Bintintan, Claudia Burz, Irena Pintea, Adriana Muntean, Diana Deleanu, Iulia Lupan, Gabriel Samasca. Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 UpdateDiagnostics 2024; 14(12): 1247 doi: 10.3390/diagnostics14121247
2
Wenzhi Wu, Ruiqing Liu, Dongsheng Wang, Yu Li, Wenchang Yang, Zheng Ma, Liang Wang, Simeng Zhang, Zongsheng Sun, Maoshen Zhang, Xianxiang Zhang. Application of computed tomography body composition in patients with locally progressive gastric cancer undergoing radical surgery combined with prophylactic hyperthermic intraperitoneal chemotherapyNutrition 2025; 132: 112686 doi: 10.1016/j.nut.2025.112686
3
Taha Koray Sahin, Deniz Can Guven. Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysisClinical Nutrition ESPEN 2024; 63: 829 doi: 10.1016/j.clnesp.2024.08.015
4
Yu-Nuo Yang, Li-Sheng Wang, Yan-Qi Dang, Guang Ji. Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitorsWorld Journal of Gastroenterology 2024; 30(32): 3726-3729 doi: 10.3748/wjg.v30.i32.3726